GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSD17B1, HSPA1A, INSR, KDR, KIT, MET, MIF, PPARA, PTAFR, PTGS1, PTGS2, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
13.6461 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
13.6461 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
13.6162 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, BCL2, CSNK2A1, CXCL8, CYP1B1, DNMT1, DRD2, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PTAFR, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
13.6162 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
12.8355 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
12.8348 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HMGCR, HSD17B1, KIT, MET, MIF, PPARA, PTGS1, PTGS2 |
12.3309 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK |
12.0371 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A2, DNMT1, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, GRM5, IGF1R, INSR, KIT, MMP2, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK |
11.8983 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, GRIK5, GRM5, HMGCR, IGF1R, INSR, MMP2, MMP9, PPARA, PTAFR, PTGS2, SRC, TEK |
11.7395 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
11.444 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
10.8237 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS1, PTGS2 |
10.7724 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
10.7603 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
10.6785 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTGS2, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
10.6785 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS1, PTGS2 |
10.4953 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
10.4759 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CSNK2A1, CXCL8, CYP1B1, DRD2, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP2, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
10.3534 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CXCL8, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PTAFR, PTGS2, SMAD3, SRC, TERT |
10.2642 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
10.1751 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
10.0263 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTAFR, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
9.81469 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, DRD2, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT, PTGS2 |
9.73904 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, DRD2, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT, PTGS2 |
9.73904 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, HMGCR, KIT, MET, MIF, PPARA, PTGS1, PTGS2 |
9.69364 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PTGS2, SRC, TEK, XDH |
9.62934 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MIF, PTGS2, SRC, TEK, XDH |
9.60239 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
9.56984 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FUT7, HMGCR, HSPA1A, MIF, PIM1, PPARA, PTAFR, PTGS1, PTGS2, XDH |
9.56827 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
9.5641 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, CXCL8, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
9.42645 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CXCL8, CYP1A1, CYP1B1, DNMT1, DRD1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, KIT, MMP2, PTAFR, PTGS2, SMAD3, SRC |
9.24181 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
9.22144 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, CXCL8, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
9.20113 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, CXCL8, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
9.00815 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, BCL2, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HMGCR, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, PIM1, PTAFR, PTGS2, TEK, TERT |
8.81884 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, GPR35, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
8.80511 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, CXCL8, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
8.7921 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, BCL2, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, XDH |
8.76511 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS1, PTGS2 |
8.76511 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CXCL8, CYP1B1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
8.76511 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, GRM1, GRM3, GRM5, GRM8, PTGS2 |
8.71925 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, BCL2, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, XDH |
8.69816 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, KIT, PPARA, PTAFR, PTGS2, SRC, TEK |
8.56835 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, CXCL8, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, PTAFR, SMAD3, SRC, TEK, TNKS, TNKS2 |
8.51106 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AURKB, BCL2, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
8.31843 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP2, MMP9, NUAK1, PTAFR, PTGS2, SMAD3, SRC, TERT |
8.21603 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.21603 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
8.17968 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
8.12852 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
7.98795 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
7.98096 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
7.97348 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FLT3, PTAFR, PTGS2, SRC, TEK |
7.91333 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, BCL2, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, MIF, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, XDH |
7.9103 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, BCL2, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, MIF, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, XDH |
7.9103 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
7.86328 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
7.75438 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, HMGCR, HSD17B1 |
7.74479 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK |
7.74479 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, APP, AURKB, BCL2, CSNK2A1, CXCL8, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KIT, MET, MIF, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, XDH |
7.74479 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
7.71097 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, XDH |
7.69769 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
7.62686 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
7.57988 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CXCL8, CYP19A1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, XDH |
7.56638 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, KIT, MMP9, PTGS2, TERT |
7.52078 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
7.4947 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, CXCL8, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPRS, SMAD3, SRC, TERT, XDH |
7.43557 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRB, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, IGF1R, INSR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TNKS2 |
7.41742 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, CXCL8, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPRS, SMAD3, SRC, TERT, XDH |
7.41742 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, BCL2, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KIT, MIF, MMP9, NUAK1, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, XDH |
7.29912 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP2, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
7.28742 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, EGFR, GRM1, HMGCR, HSPA1A, KIT, MMP2, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT |
7.20383 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7, GRM5, PTAFR |
7.06148 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTAFR, PTGS2, PTPRS, SRC, TEK, TNKS, XDH |
7.00659 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTAFR, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT |
6.96325 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AXL, CXCL8, CYP1B1, DNMT1, DRD1, EGFR, ESR1, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, PTAFR, PTGS2, SRC |
6.92277 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.90233 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, KIT, MIF, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, XDH |
6.84148 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.84148 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
6.80967 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, CXCL8, DNMT1, DRD1, EGFR, ESR1, FLT3, GRM5, IGF1R, INSR, KIT, MMP2, PTAFR, PTGS2, SMAD3, SRC |
6.76897 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, BCL2, CA2, CXCL8, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PTAFR, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS2, XDH |
6.76838 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.76184 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
6.7001 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CXCL8, CYP19A1, DRD1, DRD2, EGFR, ESR1, F3, FABP4, HMGCR, KDR, MET, MIF, MMP12, PPARA, PTGS2, PTPRS, SMAD3, TEK |
6.68626 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, BCL2, CA2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, INSR, KDR, KIT, PPARA, PTPRS, SMAD3, SRC, TEK |
6.68626 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, DNMT1, DRD2, DYRK1A, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, KIT, MIF, MMP9, PTAFR, PTGS2, SMAD3, SRC, TEK, XDH |
6.68315 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CXCL8, CYP1B1, DRD2, EGFR, ESRRB, F3, HMGCR, HSPA1A, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PTAFR, PTGS2, SLC1A1, SMAD3, SRC, TEK, TERT |
6.66949 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTAFR, PTGS2, PTPRS, SRC, TEK, TNKS, XDH |
6.61282 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTAFR, PTGS2, TERT |
6.54337 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, PTAFR, PTGS2, SRC |
6.44482 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, EGFR, F3, INSR, KIT, MET, SRC, TEK, XDH |
6.39942 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD1, DRD2, EGFR, HMGCR, KDR, MIF, PTGS2, SRC, TNKS, TNKS2 |
6.39785 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HMGCR, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS2 |
6.32199 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, SRC, TERT |
6.32199 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, EGFR, GPR35, GRIK5, GRM5, HMGCR, HSPA1A, INSR, MIF, MMP12, MMP9, PPARA, PTAFR, PTGS2, SMAD3, SRC, TERT |
6.30201 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AXL, BCL2, CA1, CA2, CSNK2A1, CXCL8, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, SMAD3, SRC, TEK, TNKS, TNKS2 |
6.28016 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, HMGCR, PTAFR |
6.24328 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, KIT, MIF, MMP9, PPARA, PTGS2, SRC, TEK, XDH |
6.19083 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
6.13788 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PTGS2, SRC, TEK, XDH |
6.10666 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, EGFR, FLT3, GRM1, HMGCR, INSR, KDR, KIT, MIF, SRC, TEK, XDH |
6.01456 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DRD2, EGFR, ESRRB, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, MIF, MMP9, PTGS2, SRC, TEK, XDH |
5.88718 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, EGFR, HSPA1A |
5.83385 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HMGCR, HSD17B1, PTGS1, PTGS2, XDH |
5.82799 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.76879 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, XDH |
5.70995 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, KDR, KIT, MIF, SRC, TEK, XDH |
5.70972 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, APP, AURKB, BCL2, DRD2, EGFR, ESR1, ESR2, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, KIT, MET, MIF, MMP9, PTAFR, SMAD3, SRC, TEK, TERT, TNKS, XDH |
5.60702 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, KIT, MIF, MMP9, PTGS2, SRC, TEK, XDH |
5.56416 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
5.55948 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TNKS |
5.54405 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CA2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESRRA, ESRRB, FLT3, INSR, KDR, KIT, MMP9, PIM1, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK |
5.52591 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
5.50577 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3 |
5.49406 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DRD2, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, MIF, MMP9, PTGS2, SRC, TEK, XDH |
5.48236 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, F3, INSR, KIT, MET, SRC, TEK |
5.48187 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
5.45012 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
5.45012 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DNMT1, DRD2, ESR1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
5.44461 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.40214 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD2, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, PTAFR, PTGS2, SRC, TEK |
5.38713 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, EGFR, INSR, MIF, MMP12, PTAFR, PTGS2, SMAD3, SRC, TERT |
5.38505 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, CXCL8, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPRS, SMAD3, SRC, TERT, XDH |
5.37617 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC |
5.33964 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
5.27671 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
5.26229 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APP, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTAFR, PTGS2, SRC |
5.25122 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, DNMT1, DRD2, DYRK1A, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, MIF, MMP9, PTGS2, SRC, TEK, XDH |
5.25122 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.25122 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PTAFR, PTGS2, SMAD3, SRC, TEK, XDH |
5.23781 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DUSP3, DYRK1A, ESR1, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP9, PTGS2, SRC, XDH |
5.15914 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
5.1194 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
5.11655 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7, GRM5, MIF, PTAFR |
5.04054 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, HMGCR |
5.01139 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD2, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, PTAFR, PTGS2, SRC, TEK |
4.95355 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AKR1C3, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTGS2, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
4.94544 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
4.94317 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTAFR, PTGS2, TERT |
4.94112 |
[BP] GO:0019371 |
None
|
AKR1C3, CBR1, PTGS1, PTGS2 |
4.86354 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, HMGCR, KDR, PTAFR, PTGS2, SRC |
4.85441 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DUSP3, ESR1, FABP4, GPR35, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TNKS |
4.83993 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
4.83512 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AKR1C3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
4.77937 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, BCL2, DRD2, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, KIT, MIF, PTAFR, SMAD3, SRC, TEK, TERT, TNKS, XDH |
4.76465 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, GRM5, HMGCR, INSR, KIT, PTGS2 |
4.75985 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, EGFR, GRM5, IGF1R, INSR, MMP2, PTAFR, PTGS2, SRC |
4.74751 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, KIT, MMP9, TERT |
4.72256 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, EGFR, GRIK5, INSR, PTGS2, SLC1A1, SMAD3 |
4.69521 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, EGFR, HMGCR, KDR, MIF, SRC, TEK |
4.62354 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HMGCR, MIF, SRC, TNKS, TNKS2 |
4.58075 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
4.507 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA, SLC1A1 |
4.50071 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
4.50071 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, KIT, MIF, SRC |
4.50071 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
4.50047 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PTAFR, PTGS2, SMAD3, SRC, TEK, XDH |
4.47881 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, EGFR, GRM5, HMGCR, INSR, KIT, PTGS2 |
4.4584 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.45163 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HMGCR, HSD17B1 |
4.44873 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.44277 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, DUSP3, EGFR, HMGCR, KDR, MIF, SRC, TEK |
4.43769 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KIT, MIF, SRC, TEK, TNKS |
4.42495 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, EGFR, GRM5, IGF1R, INSR, MMP2, PTAFR, PTGS2, SRC |
4.41587 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, BCL2, CA2, CA7, DRD1, DRD2, GPR35, GRM5, MIF, MMP9, PTAFR, PTGS2 |
4.38524 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, HMGCR, MIF, PPARA, PTPRS, SMAD3, TEK |
4.38061 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCL2, EGFR, FLT3, PTAFR, PTGS2, SRC |
4.38061 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, EGFR, HMGCR, PTAFR, PTGS2, SRC, TEK |
4.38061 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSPA1A, KIT, MIF, MMP2, MMP9, NUAK1, PPARA, PTAFR, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT |
4.37045 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DUSP3, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
4.34111 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
4.34111 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.33983 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DYRK1A, EGFR, ESR1, KIT, PPARA, SRC |
4.32356 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HMGCR, MIF, PTAFR, PTGS1, PTGS2 |
4.32315 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, MMP9, SRC |
4.32147 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TNKS |
4.32108 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, BCL2, CA2, EGFR, FLT3, PTAFR, PTGS2, SRC |
4.30051 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, AKR1C3, CYP1A1, FABP3, FLT3, HMGCR, KIT, PPARA, PTGS2, SRC, TEK |
4.27658 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, MIF, PTGS1, PTGS2 |
4.25907 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, EGFR, PTGS2, TNKS, TNKS2 |
4.1957 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.17714 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.14974 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
4.14974 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
4.13405 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, BCL2, CYP1B1, EGFR, INSR, PTGS2, SMAD3, XDH |
4.13386 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KIT, MIF, SRC, TEK |
4.13274 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD17B1, MIF, PTGS1, PTGS2 |
4.10794 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, DYRK1A, EGFR, HMGCR, HSPA1A, IGF1R, MET, MIF, NUAK1, PTGS2, PTPRS, TERT, XDH |
4.09782 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
4.08342 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, EGFR, GRM5, HMGCR, INSR, KIT, PTGS2 |
4.07471 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, KIT, MET, MIF, PIM1, SRC, TEK |
4.06383 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
4.05094 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, BCL2, CA2, CXCL8, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, F3, HMGCR, INSR, KDR, KIT, MIF, NUAK1, PIM1, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS2, XDH |
4.04837 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CXCL8, CYP1B1, F3, KDR, KIT, PTGS2, TEK, TERT |
4.03575 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, GRM1, GRM3, GRM5, GRM8 |
4.03343 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC, TEK |
3.98321 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK, TNKS |
3.96259 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
3.96259 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, GPR35, GRM1, GRM5, SMAD3 |
3.96189 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AXL, BCL2, CBR1, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, HMGCR, KDR, KIT, MET, MIF, MMP2, MMP9, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT |
3.92567 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, DRD1, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.91118 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, HMGCR, KDR, SRC |
3.8919 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, DNMT1, EGFR, FABP3, KDR, MMP2, PTAFR, PTGS2, SRC |
3.8919 |
[BP] GO:0051172 |
None
|
APP, AURKB, CSNK2A1, DNMT1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, MIF, MMP12, MMP9, PPARA, PTGS2, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
3.8919 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK |
3.86378 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KIT, MIF, SRC |
3.85355 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, SRC, TEK |
3.81556 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FLT3, FUT7, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.81556 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AXL, BCL2, CA2, CXCL8, CYP1B1, DRD2, ESRRB, F3, HMGCR, INSR, KDR, KIT, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
3.80203 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.79513 |
[BP] GO:0040011 |
locomotion
|
AXL, CXCL8, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MET, MIF, MMP1, MMP12, MMP9, PTAFR, SRC, TEK |
3.78984 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
3.7725 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, BCL2, CA2, CXCL8, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HSPA1A, KIT, MIF, MMP12, MMP2, PTAFR, PTPRS, SMAD3, SRC |
3.76864 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, HMGCR, KIT |
3.757 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.7457 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTAFR, PTGS2, SMAD3, SRC, TERT, TNKS, TNKS2 |
3.74313 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC, TERT, TNKS |
3.68009 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, BCL2, CSNK2A1, CXCL8, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, PTGS2, SMAD3, SRC, TERT, TNKS |
3.67852 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
AKR1C3, EGFR, INSR, PTGS2, SMAD3, XDH |
3.65373 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.65247 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.65247 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.64448 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
3.62245 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, PTAFR, SRC |
3.60228 |
[BP] GO:0016477 |
cell migration
|
AXL, CXCL8, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MIF, MMP1, MMP12, MMP9, SRC, TEK |
3.59213 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, EGFR, HMGCR, PTAFR, PTGS2, SRC, TEK |
3.59107 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.59107 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, HMGCR, KIT |
3.56686 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, KDR, SRC |
3.54738 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CXCL8, EGFR, F3, FABP4, KDR, MET, MIF, PTGS2, SMAD3 |
3.5421 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTGS2, SRC |
3.53647 |
[BP] GO:0050927 |
None
|
CXCL8, F3, KDR, SMAD3 |
3.51141 |
[BP] GO:0048169 |
None
|
APP, DRD2, GRM5, KIT |
3.51141 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, PTAFR, PTGS2, SRC |
3.51121 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD1, DRD2, EGFR, GRM1, GRM5, HMGCR, INSR, KIT, PPARA, PTGS2 |
3.51121 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, PPARA, PTAFR, PTGS1, PTGS2, SMAD3 |
3.50597 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
3.4848 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.4848 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, DNMT1, DRD2, EGFR, ESR1, ESR2, GRIK5, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.4848 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, EGFR, HMGCR, KIT, PTGS2 |
3.4848 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.4848 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.4848 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.4848 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA, SLC1A1 |
3.4848 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
3.47543 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2 |
3.47543 |
[BP] GO:0050926 |
None
|
CXCL8, F3, KDR, SMAD3 |
3.46638 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.46638 |
[BP] GO:0006693 |
None
|
AKR1C3, MIF, PTGS1, PTGS2 |
3.46638 |
[BP] GO:0006692 |
None
|
AKR1C3, MIF, PTGS1, PTGS2 |
3.46638 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CXCL8, CYP1B1, F3, KDR, PTGS2, TEK, TERT |
3.43643 |
[BP] GO:0048167 |
None
|
ADORA1, APP, DRD1, DRD2, GRM5, KIT, PTGS2 |
3.43643 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AXL, BCL2, CA2, CXCL8, CYP1B1, DRD2, EGFR, ESR1, ESRRA, F3, HMGCR, INSR, KDR, KIT, PIM1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, XDH |
3.43643 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CYP1A1, DRD2, DUSP3, EGFR, INSR, MIF, SRC, TERT |
3.43595 |
[BP] GO:0007154 |
None
|
ADORA1, AKR1C3, AXL, BCL2, DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PTGS2, SLC1A1, TEK |
3.42742 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, INSR, KIT, MMP2, MMP9, PTAFR, PTGS2, SRC |
3.42514 |
[BP] GO:0007188 |
None
|
ADORA1, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 |
3.40565 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.38021 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.37334 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
3.37014 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, PPARA, PTAFR, PTGS2, SMAD3, SRC, TERT, TNKS, TNKS2 |
3.369 |
[BP] GO:0010359 |
None
|
ABCB1, GRM5, PTAFR |
3.34152 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.34152 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD17B1 |
3.31773 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, ALOX15, CYP19A1, CYP3A4, HMGCR, PTAFR |
3.31143 |
[BP] GO:0022898 |
None
|
ABCB1, APP, BCL2, DRD2, GPR35, GRM5, MMP9, PTAFR |
3.31067 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, AKR1C3, APP, BCL2, CYP1B1, DRD1, DRD2, EGFR, GRM1, GRM5, GRM8, HMGCR, INSR, KIT, PTAFR, PTGS2, SRC, TEK |
3.30621 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, SMAD3, SRC, TEK |
3.3037 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, MIF, PTGS1, PTGS2 |
3.30089 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CXCL8, CYP1B1, DNMT1, DRD1, DRD2, EGFR, GRM5, IGF1R, INSR, KDR, KIT, MET, MIF, NUAK1, PTAFR, SRC, TEK |
3.28434 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, GRM5, KIT, MIF, SRC |
3.28096 |
[BP] GO:0008406 |
gonad development
|
AKR1C3, BCL2, CYP19A1, ESR1, INSR, KIT |
3.28021 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3, HMGCR |
3.24926 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.24926 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, DRD2, EGFR, FLT3, GRM1, GRM5, INSR, KIT, MIF, SRC, TEK, TNKS |
3.24147 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, PTGS2 |
3.23534 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.21149 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
3.19581 |
[BP] GO:0048870 |
cell motility
|
AXL, CXCL8, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MIF, MMP1, MMP12, MMP9, SRC, TEK |
3.18243 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.18243 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, PTGS1 |
3.15786 |
[BP] GO:0032409 |
None
|
ABCB1, APP, BCL2, DRD2, GPR35, GRM5, MMP9, PTAFR |
3.14908 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.14681 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, BCL2, CXCL8, CYP1B1, DRD2, FABP3, HSPA1A, PTGS2, SMAD3, TERT, XDH |
3.13417 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AXL, BCL2, CYP19A1, EGFR, ESR1, ESRRB, INSR, KIT, PTGS2, SRC |
3.12778 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.12698 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, PTAFR, SRC |
3.12174 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, KIT, MIF, SRC |
3.11355 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
3.10442 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.10442 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, ESR1, KIT, PTAFR |
3.10442 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, HMGCR |
3.09805 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.09805 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DNMT1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TNKS, TNKS2 |
3.09631 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, DRD2, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.05244 |
[BP] GO:1901342 |
regulation of vasculature development
|
CXCL8, CYP1B1, F3, KDR, KIT, PTGS2, TEK, TERT, XDH |
3.05071 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, HMGCR, KIT |
3.04651 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2 |
3.04246 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CXCL8, CYP19A1, F3, KDR, MET, MIF, SMAD3 |
3.03803 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD1, DRD2 |
3.03803 |
[BP] GO:0007187 |
None
|
ADORA1, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 |
3.02379 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
3.02261 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
3.01804 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, DRD2, EGFR, GPR35, GRM1, KIT, PTAFR, PTGS2, SLC1A1, SMAD3 |
3.01212 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.99423 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, BCL2, CXCL8, EGFR, FLT3, FUT7, HSPA1A, KIT, MIF, MMP9, PTAFR, SMAD3, SRC |
2.99423 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, EGFR, HMGCR, PTAFR, PTGS2 |
2.98866 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, EGFR, HMGCR, PTAFR, PTGS2 |
2.98866 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
EGFR, ESR1, KIT, PTAFR |
2.9764 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.97344 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2 |
2.97344 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.97344 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.97344 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.97344 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.97344 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.97344 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.97304 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HMGCR, HSD17B1 |
2.96486 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, CXCL8, KIT, MIF, PTAFR, PTGS1, PTGS2 |
2.93684 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, GRM1, INSR, KIT, MIF, SRC |
2.93253 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.9073 |
[BP] GO:0034762 |
None
|
ABCB1, APP, BCL2, CA2, DRD1, DRD2, GPR35, GRM5, MMP9, PTAFR |
2.90648 |
[BP] GO:0001516 |
None
|
MIF, PTGS1, PTGS2 |
2.90648 |
[BP] GO:0046457 |
None
|
MIF, PTGS1, PTGS2 |
2.90648 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC, TERT |
2.89659 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.89659 |
[BP] GO:0071229 |
cellular response to acid chemical
|
AKR1C3, DNMT1, EGFR, KDR, MMP2, PTAFR, SRC |
2.89508 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, BCL2, CYP19A1, ESR1, INSR, KIT, SRC |
2.87242 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, EGFR, HMGCR, PTAFR, PTGS2 |
2.86444 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, EGFR, HMGCR, PTAFR, PTGS2 |
2.8491 |
[BP] GO:0070542 |
None
|
AKR1C3, FABP3, PTAFR, PTGS2, SRC |
2.8448 |
[BP] GO:1901570 |
None
|
ALOX15, ALOX5, MIF, PTGS1, PTGS2 |
2.8448 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CXCL8, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MIF, MMP1, MMP12, MMP9, PTGS2, SRC, TEK, TUBB3 |
2.84461 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTAFR, SMAD3, SRC, TERT, TNKS, TNKS2 |
2.84461 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, DRD2, EGFR, FLT3, GRM1, GRM5, INSR, KIT, MIF, SRC, TEK |
2.84067 |
[BP] GO:0040008 |
regulation of growth
|
APP, BCL2, CSNK2A1, DRD2, EGFR, ESR2, HSPA1A, INSR, PIM1, PTPRS, SMAD3, TNKS2 |
2.83554 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, GRIK5, GRM1, GRM5, SMAD3 |
2.83554 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, AKR1C3, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TERT, TNKS, TNKS2 |
2.83055 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.82638 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP1B1, CYP3A4, HMGCR, PTAFR |
2.82319 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, BCL2, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT, TNKS |
2.8009 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.79683 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.79683 |
[BP] GO:0051179 |
None
|
ABCB1, ACHE, ADORA1, AKR1C3, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CXCL8, DRD1, DRD2, EGFR, ESR1, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, KIT, MIF, MMP12, MMP9, PPARA, PTAFR, SLC1A1, SRC, TERT, TNKS, TNKS2, XDH |
2.78915 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, KIT, PTAFR, PTGS2 |
2.78276 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.76389 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, PTAFR, PTGS2 |
2.76275 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, PPARA, PTAFR |
2.76089 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.75941 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CXCL8, CYP1B1, DUSP3, KDR, NUAK1, PPARA, PTAFR, SMAD3, SRC, TEK |
2.74742 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.74403 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, GPR35, MMP9, PTGS2 |
2.73389 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.72692 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.72692 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.71925 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, AKR1C3, APP, CA2, CXCL8, DRD1, DRD2, ESR1, GPR35, GRM1, GRM3, GRM5, GRM8, INSR, PTAFR, SRC |
2.70426 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTGS2, SRC, TERT |
2.70203 |
[BP] GO:0045934 |
None
|
AURKB, DNMT1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HSPA1A, MMP12, PPARA, SMAD3, SRC, TERT, TNKS, TNKS2 |
2.68304 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.67357 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.67357 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.67093 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.67093 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.67093 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.67093 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.66321 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, EGFR, MIF, MMP12, PTAFR, SRC |
2.65632 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.64852 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.61256 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.61256 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2, SMAD3, TEK |
2.60877 |
[BP] GO:0051234 |
None
|
ABCB1, ACHE, ADORA1, AKR1C3, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CXCL8, DRD1, DRD2, EGFR, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, KIT, MIF, MMP12, MMP9, PPARA, PTAFR, SLC1A1, SRC, TERT, TNKS, XDH |
2.60074 |
[BP] GO:0008584 |
None
|
AKR1C3, BCL2, ESR1, INSR, KIT |
2.59955 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.59939 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, KIT, MET, MMP1, SMAD3, SRC, TEK |
2.59935 |
[BP] GO:0032412 |
None
|
ABCB1, APP, DRD2, GPR35, GRM5, MMP9, PTAFR |
2.58424 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.58097 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.58097 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58097 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.58097 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.58078 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
CYP1B1, DRD2, HSPA1A, MIF, MMP12, PTAFR, PTGS2, SMAD3, SRC |
2.56474 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AURKB, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, IGF1R, KDR, MIF, MMP12, MMP9, PPARA, PTGS2, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
2.56166 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.54131 |
[BP] GO:2000351 |
None
|
AKR1C3, KDR, TEK, TERT |
2.54059 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
EGFR, ESR1, KIT, PTAFR |
2.54059 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.53906 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, AKR1C3, BCL2, DRD2 |
2.53038 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, KIT, TEK |
2.51069 |
[BP] GO:0016101 |
None
|
AKR1B10, AKR1C3, CYP1A1, CYP1B1, EGFR |
2.51069 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTGS2, SRC |
2.50413 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
AKR1C3, BCL2, CYP1B1, F3, GRIK5, HMGCR, MMP9, PTGS2, SMAD3, SRC, XDH |
2.50039 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, KIT, MET |
2.50039 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, BCL2, CSNK2A1, CYP1A1, DRD2, EGFR, HSPA1A, INSR, MIF, TERT, TNKS |
2.5001 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CYP1A1, HMGCR, MIF, PTGS2, TERT |
2.5001 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CYP19A1, DRD2, DUSP3, MIF, MMP12, PTPRS |
2.48761 |
[BP] GO:0048168 |
None
|
APP, DRD2, GRM5, KIT |
2.4834 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.47991 |
[BP] GO:0033138 |
positive regulation of peptidyl-serine phosphorylation
|
APP, BCL2, EGFR, MIF, PTGS2 |
2.47991 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
AKR1C3, BCL2, CYP1B1, F3, GRIK5, HMGCR, MMP9, PTGS2, SMAD3, SRC, XDH |
2.47196 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, ESRRB, GRM3, GRM8, INSR, PPARA |
2.47196 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.45706 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.45706 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.45142 |
[BP] GO:0001817 |
regulation of cytokine production
|
AXL, CYP1B1, DRD2, HSPA1A, MIF, MMP12, PTAFR, PTGS2, PTPRS, SMAD3, SRC |
2.44721 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.44721 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.44721 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.44721 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.44721 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, DRD2, EGFR, FLT3, GRM1, GRM5, INSR, KIT, MIF, SRC |
2.43735 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.43293 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, DRD2, EGFR, MIF, MMP12, PTGS2, SMAD3, SRC |
2.43293 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.43197 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.42686 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.42686 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.41522 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, ESRRB, GRM3, GRM8, INSR, PPARA |
2.40943 |
[BP] GO:0007267 |
None
|
ADORA1, DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.40943 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.40943 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.40943 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.40303 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD1, DRD2, EGFR, HMGCR, KIT, PTGS2 |
2.38626 |
[BP] GO:0048565 |
None
|
CXCL8, CYP1A1, EGFR, KIT |
2.38141 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, CXCL8, EGFR, INSR, KDR, SMAD3, SRC |
2.37227 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.37227 |
[BP] GO:1903959 |
None
|
ABCB1, GRM5, PTAFR |
2.37227 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.37227 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.36689 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, DNMT1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, KIT, MET, MMP12, PPARA, PTAFR, SMAD3, SRC, TERT, TNKS |
2.35429 |
[BP] GO:0002685 |
None
|
ADORA1, APP, CXCL8, CYP19A1, MIF, PTAFR |
2.34162 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.33981 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.33981 |
[BP] GO:1901529 |
None
|
ABCB1, PTAFR |
2.33981 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33981 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.33981 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, KIT, MIF, SRC |
2.33832 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.33832 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.33832 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, BCL2, CYP1A1, EGFR, HMGCR, PTGS2, SRC |
2.32953 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.32686 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.32686 |
[BP] GO:0035295 |
tube development
|
AKR1B1, CXCL8, CYP1A1, EGFR, KIT, SMAD3 |
2.31485 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, XDH |
2.31287 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
EGFR, ESR1, KIT, PTAFR |
2.28492 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, MIF, MMP12, SRC |
2.28492 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, PTAFR, SRC |
2.27761 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27224 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, BCL2, DRD1, DRD2, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.26869 |
[BP] GO:0050877 |
None
|
ADORA1, APP, CYP1B1, DRD1, DRD2, EGFR, GRM1, GRM5, GRM8, HMGCR, INSR, KIT, PTGS2 |
2.2665 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.26215 |
[BP] GO:0022603 |
regulation of anatomical structure morphogenesis
|
BCL2, CXCL8, CYP1B1, ESR1, F3, KDR, KIT, PIM1, PTGS2, PTPRS, SRC, TEK, TERT, XDH |
2.2557 |
[BP] GO:0050776 |
regulation of immune response
|
ALOX15, BCL2, DRD2, DUSP3, ESR1, HSPA1A, KIT, MIF, MMP12, MMP2, PTAFR, PTPRS, SMAD3, SRC |
2.24839 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADORA3, AKR1C3, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KIT, MET, MMP12, PIM1, PPARA, PTAFR, PTGS2, SMAD3, SRC, TERT, TNKS, TNKS2 |
2.24549 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CYP1A1, DRD1, EGFR, ESR1, KIT, PTGS2, SRC |
2.24338 |
[BP] GO:0010942 |
positive regulation of cell death
|
AKR1C3, BCL2, CYP1B1, F3, GRIK5, HMGCR, MMP9, PTGS2, SMAD3, SRC, XDH |
2.23957 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.23009 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.22717 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.22717 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.22717 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, FLT3, GRM1, INSR, KIT, MIF, SRC |
2.22656 |
[BP] GO:0050900 |
leukocyte migration
|
CXCL8, FUT7, KIT, MIF, MMP1, MMP9, SRC, TEK |
2.22656 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
EGFR, ESR1, KIT, PTAFR |
2.21656 |
[BP] GO:0006811 |
None
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
2.2152 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.2152 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, GRIK5, GRM1, GRM5, SMAD3 |
2.20283 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.20106 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F3, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.20041 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.19914 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, MIF, MMP12, PTAFR, SRC |
2.19435 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, AXL, CXCL8, EGFR, ESR1, FLT3, PTAFR, SRC |
2.19435 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.19192 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, SMAD3, SRC, TEK |
2.1756 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.1756 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.16277 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.16277 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.16277 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.16277 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.16277 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.16277 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.15818 |
[BP] GO:0006940 |
None
|
ADORA1, KIT, PTAFR, PTGS2 |
2.15818 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
BCL2, DRD2, GPR35, PTGS2 |
2.15818 |
[BP] GO:0010675 |
None
|
ESRRB, INSR, PPARA, PTAFR, SRC |
2.15332 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, EGFR, GRIK5, HMGCR, MIF, MMP12, PTAFR, SRC |
2.15053 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.15053 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.15053 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.15053 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
APP, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, KIT, MMP9, NUAK1, PTAFR, PTGS2, SMAD3, SRC, XDH |
2.15031 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, KIT, TEK |
2.14173 |
[BP] GO:0007584 |
response to nutrient
|
AKR1C3, ALPL, CYP1A1, EGFR, HMGCR, PTGS2 |
2.13324 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, TNKS2 |
2.11855 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2 |
2.11506 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CXCL8, CYP1A1, CYP1A2, PTGS2, SRC |
2.11364 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.10988 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.10988 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, DRD2, EGFR, HMGCR, MIF, MMP12, PTGS2, SMAD3, SRC |
2.10655 |
[BP] GO:0070848 |
response to growth factor
|
APP, CXCL8, EGFR, INSR, KDR, SMAD3, SRC |
2.09807 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.08929 |
[BP] GO:0033043 |
regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, GRIK5, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.08386 |
[BP] GO:0023052 |
None
|
ADORA1, DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.08074 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.07751 |
[BP] GO:0006810 |
None
|
ABCB1, ACHE, ADORA1, AKR1C3, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CXCL8, DRD1, DRD2, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, KIT, MIF, MMP12, MMP9, PPARA, PTAFR, SLC1A1, SRC, TNKS, XDH |
2.07408 |
[BP] GO:0051482 |
None
|
DRD1, GPR35, GRM1 |
2.06962 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA3, PTAFR |
2.06962 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.06962 |
[BP] GO:0048568 |
None
|
CXCL8, EGFR, ESRRB, KDR, KIT |
2.06201 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.05887 |
[BP] GO:0031644 |
None
|
ADORA1, GPR35, GRM1, PTAFR |
2.05887 |
[BP] GO:1903524 |
None
|
EGFR, PTAFR, PTGS2, SLC1A1 |
2.05887 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
DRD1, DRD2, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.05213 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, DRD2, EGFR, PTAFR, PTGS2, SLC1A1 |
2.05213 |
[BP] GO:0050921 |
positive regulation of chemotaxis
|
CXCL8, F3, KDR, MET, SMAD3 |
2.05086 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, DRD2, EGFR, MIF, MMP12, PTGS2, SMAD3, SRC |
2.05086 |
[BP] GO:1900543 |
None
|
DRD2, GRM3, GRM8, PPARA |
2.03852 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTGS2, SMAD3, SRC, TERT |
2.03838 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.03382 |
[BP] GO:0033135 |
regulation of peptidyl-serine phosphorylation
|
APP, BCL2, EGFR, MIF, PTGS2 |
2.03382 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.03382 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.03382 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.03382 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.03382 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.03382 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.03382 |
[BP] GO:1903961 |
None
|
ABCB1, PTAFR |
2.03382 |
[BP] GO:1904306 |
None
|
KIT, PTAFR |
2.03382 |
[BP] GO:1904304 |
None
|
KIT, PTAFR |
2.03382 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.03382 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.03382 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.03382 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.03382 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.03382 |
[BP] GO:0045980 |
None
|
DRD2, GRM3, GRM8, PPARA |
2.03101 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, NUAK1, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.01328 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.00993 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.00504 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.00504 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, IGF1R |
2.00504 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, CYP1B1, ESR1, ESR2, HSPA1A, KIT, PIM1 |
2.00366 |
[BP] GO:0051052 |
regulation of DNA metabolic process
|
AURKB, DNMT1, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.00366 |
[BP] GO:0045321 |
leukocyte activation
|
ALOX5, AXL, BCL2, CXCL8, FLT3, FUT7, HSPA1A, KIT, MIF, MMP9, PTAFR, SMAD3 |
2.00237 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ALOX15, APP, AXL, BACE1, CA2, CA4, CA9, DRD1, DRD2, DUSP3, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PTAFR, PTGS2, PTPRS, SLC1A1, SRC, TEK |
6.92568 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, CA2, CA4, CA9, DRD1, DRD2, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, PTGS2, SLC1A1, SRC, TEK |
6.68315 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, BACE1, CA4, DRD1, DRD2, F3, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTAFR, PTPRS, SLC1A1, TEK |
5.73633 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, PTAFR, PTPRS, SLC1A1, SMAD3, SRC, TEK, TERT |
5.42455 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, BACE1, DRD1, DRD2, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTAFR, PTPRS, SLC1A1, TEK |
4.84076 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, EGFR, ESR1, F3, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, PTAFR, PTGS1, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2 |
4.48304 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
4.24624 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GRIA4, GRIK5, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
3.86229 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, KIT, MET, PTAFR, PTGS1, PTGS2, PTPRS, SLC1A1, SRC, TEK |
3.83647 |
[CC] GO:0043005 |
None
|
ADORA1, APP, BACE1, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, PTPRS, SRC, TUBB3 |
3.82982 |
[CC] GO:0044421 |
None
|
ABCB1, ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, AXL, CA1, CA2, CA4, CBR1, CXCL8, DUSP3, EGFR, ESRRA, F3, FABP3, FABP4, GRIA4, GRM5, HSPA1A, INSR, KIT, MIF, MMP1, MMP12, MMP2, MMP9, PTGS1, PTPRS, SLC1A1, SRC, TUBB3, XDH |
3.3037 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.29458 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTPRS, SRC |
3.18199 |
[CC] GO:0043235 |
receptor complex
|
APP, EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 |
3.12778 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, BACE1, CA2, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, PTPRS, SRC, TEK, TUBB3 |
3.10442 |
[CC] GO:0043197 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.09166 |
[CC] GO:0044309 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.05244 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, APP, AXL, BACE1, CA4, EGFR, F3, MET, MIF, TEK |
2.87184 |
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.84779 |
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.84779 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, BACE1, CA2, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, PTPRS, SRC, TEK, TUBB3 |
2.84188 |
[CC] GO:0097458 |
None
|
ADORA1, APP, BACE1, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, PTGS1, PTGS2, PTPRS, SRC, TUBB3 |
2.79023 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, EGFR, FLT3, GRIA2, HMGCR, PTGS1, PTGS2 |
2.69776 |
[CC] GO:0045121 |
membrane raft
|
APP, BACE1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.66792 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, EGFR, GRIA2, HMGCR, PTGS1, PTGS2 |
2.65742 |
[CC] GO:0098857 |
membrane microdomain
|
APP, BACE1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.6509 |
[CC] GO:0098794 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
2.58097 |
[CC] GO:1903561 |
None
|
ABCB1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APP, AXL, CA1, CA2, CA4, CBR1, DUSP3, F3, FABP3, FABP4, GRIA4, GRM5, HSPA1A, INSR, MIF, MMP9, PTGS1, PTPRS, SLC1A1, SRC, TUBB3 |
2.50039 |
[CC] GO:0043230 |
None
|
ABCB1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APP, AXL, CA1, CA2, CA4, CBR1, DUSP3, F3, FABP3, FABP4, GRIA4, GRM5, HSPA1A, INSR, MIF, MMP9, PTGS1, PTPRS, SLC1A1, SRC, TUBB3 |
2.5001 |
[CC] GO:0031982 |
None
|
ABCB1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APP, AXL, BACE1, CA1, CA2, CA4, CBR1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, GRIA4, GRM5, HSPA1A, INSR, KDR, KIT, MIF, MMP9, PTGS1, PTPRS, SLC1A1, SRC, TUBB3 |
2.43197 |
[CC] GO:0044464 |
cell part
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, XDH |
2.38153 |
[CC] GO:0031090 |
None
|
ALOX5, APP, BACE1, BCL2, CA4, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, EGFR, FUT7, GRIA2, GRIA4, HMGCR, INSR, PTAFR, PTGS1, PTGS2, SMAD3, SRC, TNKS, TNKS2 |
2.36459 |
[CC] GO:0030424 |
None
|
APP, BACE1, CA2, DRD2, GRM3, PTPRS, TUBB3 |
2.26707 |
[CC] GO:0070062 |
None
|
ABCB1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APP, AXL, CA1, CA2, CA4, CBR1, DUSP3, F3, FABP3, FABP4, GRM5, HSPA1A, INSR, MIF, MMP9, PTGS1, PTPRS, SLC1A1, SRC, TUBB3 |
2.25105 |
[CC] GO:0098589 |
membrane region
|
APP, BACE1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.20433 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.19565 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, INSR, PTGS1, SRC |
2.14671 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, INSR, PTGS1, SRC |
2.14671 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.03838 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, TNKS, XDH |
13.5675 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, XDH |
12.978 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DUSP3, DYRK1A, EGFR, F3, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS1, PTGS2, PTPRS, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, XDH |
10.9505 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.88592 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PPARA, PTAFR, TEK |
8.87249 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.54218 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
8.21603 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.12037 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PPARA, PTAFR, TEK |
7.83017 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
7.71191 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PPARA, PTAFR, SMAD3, TEK |
7.62686 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PPARA, PTAFR, TEK |
7.57481 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH |
7.52078 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS1, PTGS2, SRC |
7.23525 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HMGCR, HSD17B1, PTGS1, PTGS2, XDH |
7.13514 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
7.00578 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS1, PTGS2, SRC |
6.94558 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
6.89651 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS1, PTGS2 |
6.53017 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS1, PTGS2, SLC1A1, SMAD3, TERT, TNKS, TNKS2, XDH |
6.4121 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DRD1, DRD2, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, SRC, TEK |
6.31749 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PTAFR, TEK |
6.30201 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PTAFR, TEK |
6.30201 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.14086 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
5.83414 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, SMAD3, TNKS |
5.71966 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HMGCR, HSD17B1, PTGS1, PTGS2, SRC, XDH |
5.47231 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, ESR1, ESR2, ESRRA, ESRRB, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS1, PTGS2, SLC1A1, SMAD3, TERT, TNKS, TNKS2, XDH |
5.33361 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.28083 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
5.25122 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR, KIT |
5.25122 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, HMGCR, HSD17B1, XDH |
4.75985 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.75985 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DRD2, DYRK1A, EGFR, ESR1, ESR2, FLT3, GRIK5, HMGCR, IGF1R, KDR, KIT, MET, MIF, MMP9, PTGS2, SMAD3, TERT, XDH |
4.42546 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.41555 |
[MF] GO:0019899 |
enzyme binding
|
APP, AURKB, BACE1, BCL2, CYP1A1, CYP1A2, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GRM5, HMGCR, HSPA1A, KIT, MET, MIF, PPARA, PTAFR, PTGS2, SMAD3, SRC, TEK, TNKS2 |
4.41541 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
4.30004 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, AOX1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTAFR, PTPRS, SLC1A1, SRC, TEK, TUBB3, XDH |
4.13386 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
3.91695 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
3.88257 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
3.757 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.71817 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.71817 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SLC1A1, SRC, TEK, TUBB3, XDH |
3.62002 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
3.4848 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.38021 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.34152 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TERT |
3.30089 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, PPARA, PTAFR |
3.29458 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HMGCR, HSD17B1 |
3.0719 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.01212 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.97344 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.97344 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.97344 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.97344 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC |
2.87758 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TUBB3, XDH |
2.85233 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TUBB3, XDH |
2.85008 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.7398 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SMAD3, SRC |
2.68544 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, AOX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PIM1, PPARA, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, TUBB3, XDH |
2.58262 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.58097 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.58097 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.58097 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.58097 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.47991 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.47991 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PPARA, SMAD3 |
2.43551 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.42686 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.33981 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.33981 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.33981 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.33981 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.33981 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.33981 |
[MF] GO:0001540 |
amyloid-beta binding
|
ACHE, BACE1, GRIA2, INSR |
2.26215 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, ADORA1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTAFR, PTPRS, SRC, TEK, TUBB3 |
2.19914 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.19627 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.18576 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, BACE1, CSNK2A1, DUSP3, DYRK1A, EGFR, F3, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPRS, SRC, TEK |
2.18452 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.16277 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.16277 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.16277 |
[MF] GO:0003674 |
molecular_function
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPRS, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, XDH |
2.15053 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.15053 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.15053 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, KIT, SMAD3 |
2.14446 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.13822 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.10988 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCB1, ADORA1, AOX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PIM1, PPARA, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, TUBB3, XDH |
2.08558 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.03838 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.03838 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.03382 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.03382 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.03382 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.01917 |